受强制性开放获取政策约束的文章 - Sabrina Oliveira了解详情
无法在其他位置公开访问的文章：5 篇
Threshold analysis and biodistribution of fluorescently labeled bevacizumab in human breast cancer
M Koch, JS de Jong, J Glatz, P Symvoulidis, LE Lamberts, ALL Adams, ...
Cancer research 77 (3), 623-631, 2017
强制性开放获取政策： European Commission, Dutch Cancer Society
Conjugation of IRDye Photosensitizers or Fluorophores to Nanobodies
V Mashayekhi, S Oliveira
Photodynamic Therapy: Methods and Protocols, 495-503, 2022
强制性开放获取政策： European Commission
Assessment of the In Vivo Response to Nanobody-Targeted PDT Through Intravital Microscopy
HS de Bruijn, ALB Seynhaeve, TLM Ten Hagen, S Oliveira, DJ Robinson
Photodynamic Therapy: Methods and Protocols, 533-545, 2022
强制性开放获取政策： European Commission
Orthotopic Breast Cancer Model to Investigate the Therapeutic Efficacy of Nanobody-Targeted Photodynamic Therapy
MM Deken, SS Bhairosingh, AL Vahrmeijer, S Oliveira
Photodynamic Therapy: Methods and Protocols, 547-556, 2022
强制性开放获取政策： European Commission
Investigation of the Therapeutic Potential of Nanobody-Targeted Photodynamic Therapy in an Orthotopic Head and Neck Cancer Model
PBAA van Driel, S Keereweer, CWGM Lowik, S Oliveira
Photodynamic Therapy: Methods and Protocols, 521-531, 2022
强制性开放获取政策： European Commission
可在其他位置公开访问的文章：33 篇
Oncologic photodynamic therapy: basic principles, current clinical status and future directions
D Van Straten, V Mashayekhi, HS De Bruijn, S Oliveira, DJ Robinson
Cancers 9 (2), 19, 2017
强制性开放获取政策： European Commission
Tumor-specific uptake of fluorescent bevacizumab–IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study
LE Lamberts, M Koch, JS de Jong, ALL Adams, J Glatz, MEG Kranendonk, ...
Clinical Cancer Research 23 (11), 2730-2741, 2017
强制性开放获取政策： European Commission, Dutch Cancer Society
Antibody or antibody fragments: implications for molecular imaging and targeted therapy of solid tumors
KT Xenaki, S Oliveira, PMP van Bergen En Henegouwen
Frontiers in immunology 8, 1287, 2017
强制性开放获取政策： Netherlands Organisation for Scientific Research
EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer
PBAA Van Driel, MC Boonstra, MD Slooter, R Heukers, MA Stammes, ...
Journal of Controlled Release 229, 93-105, 2016
强制性开放获取政策： Netherlands Organisation for Scientific Research, European Commission
Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy
M Talelli, S Oliveira, CJF Rijcken, EHE Pieters, T Etrych, K Ulbrich, ...
Biomaterials 34 (4), 1255-1260, 2013
强制性开放获取政策： German Research Foundation
Preclinical and clinical evidence of immune responses triggered in oncologic photodynamic therapy: clinical recommendations
I Beltrán Hernández, Y Yu, F Ossendorp, M Korbelik, S Oliveira
Journal of clinical medicine 9 (2), 333, 2020
强制性开放获取政策： European Commission
Gold nanoclusters: imaging, therapy, and theranostic roles in biomedical applications
SM van de Looij, ER Hebels, M Viola, M Hembury, S Oliveira, ...
Bioconjugate Chemistry 33 (1), 4-23, 2021
强制性开放获取政策： Netherlands Organisation for Scientific Research
Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti‐epidermal growth factor receptor nanobody
PBAA Van Driel, JR van der Vorst, FPR Verbeek, S Oliveira, TJA Snoeks, ...
International journal of cancer 134 (11), 2663-2673, 2014
强制性开放获取政策： US National Institutes of Health, Netherlands Organisation for Health …
Patient-derived head and neck cancer organoids recapitulate EGFR expression levels of respective tissues and are responsive to EGFR-targeted photodynamic therapy
E Driehuis, S Spelier, I Beltrán Hernández, R de Bree, S M. Willems, ...
Journal of clinical medicine 8 (11), 1880, 2019
强制性开放获取政策： European Commission
Nanobody-targeted photodynamic therapy selectively kills viral GPCR-expressing glioblastoma cells
TWM De Groof, V Mashayekhi, TS Fan, ND Bergkamp, J Sastre Toraño, ...
Molecular pharmaceutics 16 (7), 3145-3156, 2019
强制性开放获取政策： Netherlands Organisation for Scientific Research, European Commission
Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session
MM Deken, MM Kijanka, IB Hernández, MD Slooter, HS de Bruijn, ...
Journal of controlled release 323, 269-281, 2020
强制性开放获取政策： European Commission
Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies
R van der Meel, WM Gallagher, S Oliveira, AE O’Connor, RM Schiffelers, ...
Drug discovery today 15 (3-4), 102-114, 2010
强制性开放获取政策： Science Foundation Ireland
Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice
KT Xenaki, B Dorresteijn, JA Muns, K Adamzek, S Doulkeridou, ...
Theranostics 11 (11), 5525, 2021
强制性开放获取政策： US National Institutes of Health, Netherlands Organisation for Scientific …
Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic …
HS de Bruijn, V Mashayekhi, TJL Schreurs, PBAA van Driel, GJ Strijkers, ...
Theranostics 10 (5), 2436, 2020
强制性开放获取政策： European Commission
VHH-photosensitizer conjugates for targeted photodynamic therapy of met-overexpressing tumor cells
R Heukers, V Mashayekhi, M Ramirez-Escudero, H de Haard, TC Verrips, ...
Antibodies 8 (2), 26, 2019
强制性开放获取政策： European Commission
出版信息和资助信息由计算机程序自动确定